These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 562250)

  • 21. Neurochemical correlates of ethanol withdrawal: alterations in serotoninergic function.
    Tabakoff B; Hoffman P; Moses F
    J Pharm Pharmacol; 1977 Aug; 29(8):471-6. PubMed ID: 19595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 6-Hydroxydopamine and 5,7-dihydroxytryptamine selectively reduce dopamine and 5-hydroxytryptamine metabolites in cerebroventricular perfusates of rats.
    Nielsen JA; Moore KE
    Pharmacol Biochem Behav; 1983 Nov; 19(5):905-7. PubMed ID: 6417682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of TRH, ethanol, and TRH-ethanol combination on activity in rats with altered monoamine content.
    Breese GR; Coyle S; Frye GD; Mueller RA
    Pharmacol Biochem Behav; 1985 Jun; 22(6):1013-8. PubMed ID: 3927322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catecholamines and serotonin in the rat central nervous system after 6-OHDA, 5-7-DHT and p-CPA.
    Reader TA; Gauthier P
    J Neural Transm; 1984; 59(3):207-27. PubMed ID: 6234377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 26. Asymmetric action of intraventricular monoamine neurotoxins.
    Gershanik OS; Heikkila RE; Duvoisin RC
    Brain Res; 1979 Oct; 174(2):345-50. PubMed ID: 487133
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug-induced rotational behaviour following unilateral intracerebral injection of saline-ascorbate solution: neurotoxicity of ascorbic acid and monoamine-independent circling.
    Waddington JL; Crow TJ
    Brain Res; 1979 Feb; 161(2):371-6. PubMed ID: 310332
    [No Abstract]   [Full Text] [Related]  

  • 28. Development of morphine tolerance and physical dependence in rats depleted of brain catecholamines by 6-hydroxydopamine.
    Elchisak MA; Rosecrans JA
    Neuropharmacology; 1979 Feb; 18(2):175-82. PubMed ID: 571053
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of intracerebral injections of 5,7-dihydroxytryptamine and 6-hydroxydopamine on the serotonin-immunoreactive cell bodies and fibers in the adult rat hypothalamus.
    Frankfurt M; Azmitia E
    Brain Res; 1983 Feb; 261(1):91-9. PubMed ID: 6404500
    [No Abstract]   [Full Text] [Related]  

  • 30. Serotonin turnover and supersensitivity after neonatal 5,7-dihydroxytryptamine.
    Mueller RA; Towle A; Breese GR
    Pharmacol Biochem Behav; 1985 Feb; 22(2):221-5. PubMed ID: 2580321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 5,7-dihydroxytryptamine on the development of tolerance to ethanol.
    Lê AD; Khanna JM; Kalant H; LeBlanc AE
    Psychopharmacology (Berl); 1980 Feb; 67(2):143-6. PubMed ID: 6768090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteration of aminophylline-induced respiratory stimulation by perturbation of biogenic amine systems.
    Mueller RA; Lundberg DB; Breese GR
    J Pharmacol Exp Ther; 1981 Sep; 218(3):593-9. PubMed ID: 7264947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
    Pranzatelli MR; Rubin G; Snodgrass SR
    Brain Res; 1986 Jan; 364(1):57-66. PubMed ID: 3484992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective neurotoxic lesions of descending serotonergic and noradrenergic pathways in the rat.
    Berge OG; Fasmer OB; Tveiten L; Hole K
    J Neurochem; 1985 Apr; 44(4):1156-61. PubMed ID: 3919157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of central catecholamine alterations by 6-hydroxydopamine on shuttle box avoidance acquistion.
    Cooper BR; Breese GR; Howard JL; Grant LD
    Physiol Behav; 1972; 9(5):727-31. PubMed ID: 4655165
    [No Abstract]   [Full Text] [Related]  

  • 36. The behavioral effects of depletions of brain serotonin induced by 5,7-dihydroxytryptamine vary with time after administration.
    Gately PF; Segal DS; Geyer MA
    Behav Neural Biol; 1986 Jan; 45(1):31-42. PubMed ID: 3954713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neonatal intraspinal 6-hydroxydopamine, 5,7-dihydroxytryptamine or their combination: effects on nociception and morphine analgesia.
    Pappas B; Ings R; Roberts D
    Eur J Pharmacol; 1982 Dec; 86(2):157-66. PubMed ID: 6819155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic differences in ethanol drinking of the rat following injection of 6-OHDA, 5,6-DHT or 5,7-DHT into the cerebral ventricles.
    Melchior CL; Myers RD
    Pharmacol Biochem Behav; 1976 Jul; 5(1):63-72. PubMed ID: 996042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Facilitation of shock-induced fighting following intraventricular 5,7-dihydroxytryptamine and 6-hydroxydopa.
    Kantak KM; Hegstrand LR; Eichelman B
    Psychopharmacology (Berl); 1981; 74(2):157-60. PubMed ID: 6791220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastrointestinal motility and body weight gain in rats after brain serotonin depletion by 5, 7-dihydroxytryptamine.
    Saller CF; Stricker EM
    Neuropharmacology; 1978 Jul; 17(7):499-506. PubMed ID: 692815
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.